kneat.com, inc. (TSX:KSI)

Market Cap	618.72M +2.4%
Revenue (ttm)	66.52M +25.7%
Net Income	-8.44M
EPS	-0.09
Shares Out	96.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,252,264
Open	6.43
Previous Close	6.43
Day's Range	6.42 - 6.44
52-Week Range	3.23 - 6.73
Beta	1.37
Analysts	Buy
Price Target	6.10 (-5.13%)
Earnings Date	May 13, 2026

About kneat.com

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.co...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2007
• Employees: 343
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: KSI

Financial Performance

In 2025, kneat.com's revenue was 63.26 million, an increase of 29.27% compared to the previous year's 48.94 million. Losses were -2.35 million, -69.61% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for KSI stock is "Buy." The 12-month stock price target is $6.10, which is a decrease of -5.13% from the latest price.

Price Target

$6.10

(-5.13% downside)

Analyst Consensus: Buy